go to main content
Research Departments Pulmonary Diseases News
News items related to the Department of Pulmonary Diseases.
Results (8)

Filter results

Anti-tuberculosis drug can be safely dosed even higher

16 March 2021

A considerably higher dose of the anti-tuberculosis drug rifampicin is safe and can also lead to a shorter treatment for tuberculosis and less resistance.

Radboudumc research most lungs recover well after COVID-19

26 November 2020

In severe COVID-19 patients the lung tissue recovers well in most cases. This is shown in research by the Radboudumc, published in Clinical Infectious Diseases. Striking conclusion: patients who were referred by the general practitioner recover worse than ICU patients.

Improved method for detecting lung cancer

24 July 2020

Radboudumc researchers are the only ones in the Netherlands using a new method to make better lung cancer diagnoses earlier stage. Erik van der Heijden and Roel Verhoeven shows that the use of flexible imaging equipment via the natural respiratory tract contributes to a more accurate diagnosis.

Strain elastography predicts lung cancer metastases

9 June 2020

The first multicenter study by researchers Roel Verhoeven and Erik van der Heijden, in which the added predictive value of elastography by means of endobronchial ultrasound of mediastinal lymph nodes in patients with lung cancer was systematically investigated.

Martin Boeree appointed as professor of Clinical Tuberculosis and other Mycobacterial Diseases

23 April 2020

Martin Boeree is searching for shorter and better treatments for drug sensitive and resistant tuberculosis. He is also conducting interdisciplinary research on treatment and clinical relevance in the area of non-tuberculous mycobacteria.

Tuberculosis medication safe in higher dosage

28 March 2019

For more than 40 years, patients with tuberculosis have been prescribed almost the same dose of rifampicin. Some studies suggest that the dose is too low and not optimal.

The potential for shortening tuberculosis treatment with higher rifampicin doses

5 July 2018

In Clinical Infectious Diseases Elin Svensson and colleagues showed that increasing rifampicin exposure shortened the time needed to reach undetectable levels of bacteria in sputum.

Tuberculosis research Martin Boeree on Euronews

7 December 2017

One of the Sustainable Development Goals is a world without tuberculosis in 2030.